SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-003070
Filing Date
2017-01-19
Accepted
2017-01-19 15:25:46
Documents
9
Period of Report
2017-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-2719_28k.htm 8-K 41373
2 EX-1.1 a17-2719_2ex1d1.htm EX-1.1 290044
3 EX-5.1 a17-2719_2ex5d1.htm EX-5.1 11348
4 EX-99.1 a17-2719_2ex99d1.htm EX-99.1 13983
5 EX-99.2 a17-2719_2ex99d2.htm EX-99.2 14081
6 GRAPHIC g27192moi001.jpg GRAPHIC 4000
7 GRAPHIC g27192kii001.jpg GRAPHIC 2234
8 GRAPHIC g27192mmi001.jpg GRAPHIC 2258
9 GRAPHIC g27192mmi002.jpg GRAPHIC 3761
  Complete submission text file 0001104659-17-003070.txt   389528
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 17535845
SIC: 2834 Pharmaceutical Preparations